Paper Details

  1. Home
  2. Paper Details

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.

Author: AgateLaura, BattagliaValentina, BiaginiAgnese, BotticiValeria, CappagliVirginia, EliseiRossella, GianiCarlotta, LorussoLoredana, MatroneAntonio, MazzeoSalvatore, MolinaroEleonora, PassannatiPaolo, PieruzziLetizia, Pontillo-ContilloBenedetta, PuleoLuciana, SabiniElena, ValerioLaura, ViolaDavid, VittiPaolo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Tyrosine kinase inhibitors (TKIs) are showing promise in the treatment of advanced cases of thyroid cancer. TKIs such as sorafenib, lenvatinib, vandetanib, and cabozantinib have been approved for use in clinical practice for different types of thyroid cancer.
Paper Details　
Original Abstract of the Article :
Thyroid cancer is rare, but it is the most frequent endocrine malignancy. Its prognosis is generally favorable, especially in cases of well-differentiated thyroid cancers (DTCs), such as papillary and follicular cancers, which have survival rates of approximately 95% at 40 years. However, 15-20% of ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1530/ERC-15-0555

データ提供：米国国立医学図書館（NLM）

Treatment of Advanced Thyroid Cancer with Targeted Therapies: Ten Years of Experience

Thyroid cancer, a type of cancer that affects the thyroid gland, is like a desert tumor, growing silently and threatening the delicate balance of the body's internal ecosystem. This research explores the use of targeted therapies, a type of treatment that specifically targets cancer cells, for treating advanced thyroid cancer. The study reviews the experience of using targeted therapies for thyroid cancer over a ten-year period.

Targeted Therapies: Fighting Advanced Thyroid Cancer

The study highlights the effectiveness of targeted therapies in treating advanced thyroid cancer, especially in cases that are resistant to conventional treatments. This is like using a specialized weapon to target and destroy a desert tumor while minimizing collateral damage to the surrounding ecosystem. The research emphasizes the importance of targeted therapies in improving outcomes for patients with advanced thyroid cancer.

Treating Advanced Thyroid Cancer

This study offers hope for patients with advanced thyroid cancer, suggesting that targeted therapies can be a valuable tool in the fight against this disease. It's a reminder that even in the challenging desert of cancer, there are advancements in treatment that offer hope for a healthier future.

Dr.Camel's Conclusion

This research provides a valuable overview of the use of targeted therapies in treating advanced thyroid cancer. It's like using a combination of strategies to combat a desert tumor, employing both traditional and innovative approaches to protect the body's internal ecosystem. The research highlights the potential of targeted therapies to improve outcomes for patients with advanced thyroid cancer, offering hope for a more balanced and healthy future.
Date :
  1. Date Completed 2017-01-19
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

27207700

DOI: Digital Object Identifier

10.1530/ERC-15-0555

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.